Questions and Answers
Which class of anti-diabetic drugs stimulate the release of insulin from the pancreas, can lead to hypoglycemia, and must be given before meals?
What may benefit a patient with sulfa allergy and elevated post prandial glucose?
Meglitinides such as repaglinide (Prandin) and nateglinide (Starlix).
Meglitinides are helpful for which type of glucose elevations?
Post-prandial
Would a patient with inflammatory bowel disease be a good candidate for therapy with a meglitinide?
Signup and view all the answers
Study Notes
Meglitinides Overview
- Meglitinides are a class of anti-diabetic drugs that stimulate insulin release from the pancreas.
- These medications can result in hypoglycemia if not monitored properly.
- Meglitinides must be taken before meals to optimize their effectiveness.
Specific Medications
- Key meglitinides include:
- Repaglinide (trade name: Prandin)
- Nateglinide (trade name: Starlix)
Targeted Use
- Meglitinides are particularly effective for controlling post-prandial (after meal) glucose elevations.
- Recommended for patients with sulfa allergies who experience elevated post-prandial glucose levels.
Cautions and Contraindications
- Not advisable for patients with inflammatory bowel disease, indicating potential contraindications or risks.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz explores the class of anti-diabetic drugs known as meglitinides, which enhance insulin release from the pancreas. You'll learn about key medications like Repaglinide and Nateglinide, their effectiveness in managing post-prandial glucose, and important precautions for their use.
